New clues to artery disease risk in guadeloupe
NCT ID NCT07233356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked for new risk factors that might lead to peripheral arterial disease (PAD), especially in the lower leg arteries. Researchers studied 123 adults in Guadeloupe, measuring things like HbA1c (a blood sugar marker) and other novel factors. The goal was to better understand why this group has more severe PAD, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
123 people
The number who actually took part.
- Started
-
Apr 2019
- Finished
-
Apr 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients having a Doppler ultra sound for known PAD or newly diagnosed PAD at hospital or at vascular doctor's offices will be proposed to participate in the study. PAD will be diagnosed if systolic pressure index\< 0.9 or toe systolic pressure \< 85 mmHg or tissue oxygen saturation \<65 mmHg or if there is a stenosis \> 50 % or an occlusion.. If the culprit lesion is infra popliteal they will be included in group 1. If the culprit lesion is supra or popliteal they will be included in group 2.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * men or women aged more than 18 years old * with PAD diagnosed with systolic pressure index (SPI) \<0.9 or toe systolic pressure \<85 mmHg or tissue oxygen saturation \< 65 mmHg or with stenosis \>50 % or occlusion of one or more arteries * Patients with or without diabetes * with stenosis \>50 % or occlusion of one or more arteries, infra popliteal, supra or popliteal * wishing to take part in the study * having signed the informed consent * Patients affiliated or beneficiary of a social security scheme Exclusion Criteria: * Patients aged less than 18 years old * Patients who do not wish to participate in the study * Patients with PAD with localization infra popliteal and supra popliteal or popliteal (stenosis \> 50 % or occlusion of an artery at supra popliteal or popliteal level AND infra popliteal level) * Patients with an history of revascularization at supra popliteal, popliteal or infra popliteal level AND stenosis on a different territory. * Patients with medial calcific sclerosis without PAD * PAD from non-atherosclerotic origin * Patient non-affiliated to the social security scheme * Pregnant or breastfeeding women
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atherosclerotic peripheral arterial disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Universitaire de la Guadeloupe
Pointe-à-Pitre, Guadeloupe, 97159, Guadeloupe
More trials for these conditions
Other studies related to the condition(s) this trial covers.